Related Experiment Video
Updated: Aug 6, 2026

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
Epigenetic and Non-Epigenetic Functions of EZH2 in Tumor Development: Structural Basis, Signaling Network, and
Yihang Wang1, Chaojiang Fu2, Jinrui Ping1
1School of Pharmaceutical Sciences and Yunnan Key Laboratory of Pharmacology for Natural Products and Yunnan College of Modern Biomedical Industry, Kunming Medical University, Kunming, Yunnan, 650500, China.
Enhancer of Zeste Homolog 2 (EZH2) is a key driver in many cancers. Inhibiting EZH2 shows promise for reactivating tumor suppressor genes and developing new anticancer therapies.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Enhancer of Zeste Homolog 2 (EZH2) is a histone methyltransferase regulating gene expression.
- EZH2 dysregulation is linked to cancer cell proliferation, differentiation, and gene silencing.
- Overexpression of EZH2 correlates with tumor aggressiveness and poor patient prognosis.
Purpose of the Study:
- To review the association between EZH2 and various cancers.
- To summarize the mechanisms and pharmacological properties of EZH2 inhibitors.
- To discuss future research directions and challenges in EZH2-targeted cancer therapy.
Main Methods:
- Literature review of studies on EZH2 function in cancer.
- Analysis of existing and emerging EZH2 inhibitors.
- Discussion of clinical trial data and preclinical findings.
Main Results:
- EZH2 inhibition can reactivate tumor suppressor genes, suppressing cancer growth and metastasis.
- Several EZH2 inhibitors (e.g., Tazemetostat, EPZ-6438, GSK126) are in development or clinical use.
- Optimization of inhibitor specificity and potency remains an ongoing challenge.
Conclusions:
- EZH2 is a critical therapeutic target in oncology.
- Targeted EZH2 inhibition offers a promising strategy for cancer treatment.
- Further research is needed to overcome challenges and advance EZH2-targeted therapies.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
10:41An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal